academic article

• Pathways to personalized medicine-Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  20:7384-7394. 2024
• APOE.  Neurology Genetics.  9:-. 2023
• Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia..  Nature communications.  13:-. 2022
• APOE.  Nature Aging.  1:919-931. 2021
• Opposing Roles of apolipoprotein E in aging and neurodegeneration..  Life science alliance.  2. 2019
• Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain..  Journal of neurochemistry.  147:24-39. 2018
• Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease..  Proceedings of the National Academy of Sciences of the United States of America.  115:E1289-E1298. 2018
• APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts..  PLoS medicine.  14:-. 2017
• Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain..  Molecular neurodegeneration.  12:-. 2017
• Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum..  Journal of neuropathology and experimental neurology.  75:516-26. 2016
• Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring..  Neurobiology of aging.  61-67. 2015
• Tau positron emission tomographic imaging in aging and early Alzheimer disease..  Annals of neurology.  79:110-9. 2015
• Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease..  The American journal of pathology.  186:375-84. 2015
• APOEε2 is associated with milder clinical and pathological Alzheimer disease..  Annals of neurology.  77:917-29. 2015
• The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort..  Alzheimer disease and associated disorders.  29:287-93. 2015
• Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses..  Acta neuropathologica communications.  -. 2014
• Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis..  The Journal of neuroscience : the official journal of the Society for Neuroscience.  34:7281-92. 2014
• Mild to moderate Alzheimer dementia with insufficient neuropathological changes..  Annals of neurology.  75:597-601. 2014
• Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain..  Science translational medicine.  5:-. 2013
• Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease..  Journal of neuropathology and experimental neurology.  72:462-71. 2013
• Calcineurin activation causes retinal ganglion cell degeneration..  Molecular vision.  2828-38. 2012
• Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease..  Nature neuroscience.  15:1422-9. 2012
• The SIST-M: predictive validity of a brief structured clinical dementia rating interview..  Alzheimer disease and associated disorders.  26:225-31. 2012
• Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain..  Neuroscience letters.  487:260-3. 2010